FDA Inspection
KBI Biopharma, Inc.KBI Biopharma, Inc. – FDA Inspection, Sep 12, 2018
Record Details
This FDA Inspection record concerns KBI Biopharma, Inc., with an inspection on September 12, 2018, issued by the Denver District Office, covering human drugs.
- Office
- Denver District Office
- People
- Jamie L. Dion (Issuing Officer)
- Ralph M. Bernstein
- Scott R. Nichols (Issuing Officer)
View Company Profile
ID · f7c07700-77b2-48bc-81f0-c04548a90ffe
Inspection Facts
- Inspection number
- 1066025
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of KBI Biopharma, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 3, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2016 | Not classified | Denver District Office |
Other documents for KBI Biopharma, Inc.
- FDA Inspection 1158021 - 2021-12-03
- FDA Inspection 994318 - 2016-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.